| abstract |
The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. Modulators of SOS1 have the following general structure of the Formula (II), n n n n n n n n n n n n or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein the variables are as defined herein. |